Cargando…
Development of In Situ Gelling Meloxicam-Human Serum Albumin Nanoparticle Formulation for Nose-to-Brain Application
The aim of this study was to develop an intranasal in situ thermo-gelling meloxicam-human serum albumin (MEL-HSA) nanoparticulate formulation applying poloxamer 407 (P407), which can be administered in liquid state into the nostril, and to increase the resistance of the formulation against mucocilia...
Autores principales: | Katona, Gábor, Sipos, Bence, Budai-Szűcs, Mária, Balogh, György Tibor, Veszelka, Szilvia, Gróf, Ilona, Deli, Mária A., Volk, Balázs, Szabó-Révész, Piroska, Csóka, Ildikó |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147280/ https://www.ncbi.nlm.nih.gov/pubmed/34062873 http://dx.doi.org/10.3390/pharmaceutics13050646 |
Ejemplares similares
-
Quality by Design Based Formulation Study of Meloxicam-Loaded Polymeric Micelles for Intranasal Administration
por: Sipos, Bence, et al.
Publicado: (2020) -
Characterizing the Drug-Release Enhancement Effect of Surfactants on Megestrol-Acetate-Loaded Granules
por: Katona, Gábor, et al.
Publicado: (2022) -
Development of Meloxicam-Human Serum Albumin Nanoparticles for Nose-to-Brain Delivery via Application of a Quality by Design Approach
por: Katona, Gábor, et al.
Publicado: (2020) -
In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin
por: Akel, Hussein, et al.
Publicado: (2021) -
Smartcrystals for Efficient Dissolution of Poorly Water-Soluble Meloxicam
por: Ambrus, Rita, et al.
Publicado: (2022)